Industry Expert Theater Breakfast

• Presented by Apellis

Exhibit Hall Break

Age-related Macular Degeneration
Session Chairs: Sophie J. Bakri, MD; Rishi P. Singh, MD

Announcements and Pretest

Submacular Hemorrhage: Clinic or OR? What Does the Data Support?
Sophie J. Bakri, MD

AI for Detecting AMD and Progression of Disease
Rishi P. Singh, MD

Sustained Drug Delivery for AMD
Jorge A. Fortun, MD

Assessing OCT Biomarkers for Geographic Atrophy
Nitish Mehta, MD

Emerging Therapies for the Treatment of GA
Caroline R. Baumal, MD

Gene Therapy for Exudative AMD
Cagri G. Besirli, MD, PhD

What Does Metformin Have to do with AMD? More Than You Think
Dimitra Skondra, MD, PhD

Optimizing Workflow in Retina Clinic
Caroline R. Baumal, MD

Discussion, Q&A and Posttest

Exhibit Hall Break

Case Conference: Macular Disease
Session Chairs: Caroline R. Baumal, MD; Yasha S. Modi, MD
Session Panel: Eric D. Nudleman, MD, PhD; David Sarraf, MD; Rishi P. Singh, MD

Break

Industry Expert Theater Lunch: Early Identification and Management Strategies for Patients With DME

• Presented by Allergan, an AbbVie company.
  Jorge Fortin, MD; Lejla Vajzovic, MD

Exhibit Hall Break

Imaging
Session Chairs: Richard B. Rosen, MD, ScD (Hon), FACS, FASRS, CRA; Nitish Mehta, MD

Pretest

Epiretinal Membrane: Mechanisms in the Development and Progression using Advanced Retinal Imaging
David Sarraf, MD

Non-perfusion (and Reperfusion) with Anti-VEGF Management in DR
Richard B. Rosen, MD, ScD (Hon), FACS, FASRS, CRA

How Imaging Helps Me Diagnose and Follow Patients with Uveitis
Yasha S. Modi, MD

Polypoidal Choroidal Vasculopathy and the Pachychoroid Spectrum
Lawrence A. Yannuzzi, MD

OCT and OCTA Biomarkers in AMD: What Should We Take Back to the Clinic
Thanos Papakostas, MD

Defining the Role of OCTA in AMD
David Sarraf, MD

Widefield OCT: What, How, and Now
Andrew A. Moshfeghi, MD, MBA

Discussion, Q&A and Posttest

Case Conference: How Imaging Helped to Seal the Diagnosis
Session Chair: Yasha S. Modi, MD; Eric D. Nudleman, MD, PhD
Session Panel: Thanos Papakostas, MD; David Sarraf, MD

Break

Controversies in Care
Session Chairs: Lejla Vajzovic, MD; Peter E. Weseley, MD

Epiretinal Membranes: Early Treatment or Watchful Waiting
Meenakashi Gupta, MD

Fovea-Sparing Rhegmatogenous RD Repair Timing: Is it an Emergency?
Talia R. Kaden, MD

Complete vs. Limited Vitreous Shaving for RRD Repair: What is Necessary?
Lejla Vajzovic, MD

Why Do We Even Talk About Fluid in AMD?
Darius M. Moshfeghi, MD

Discussion and Q&A

Business of Retina and Practice Management
Session Chairs: Vaidehi S. Dedania, MD; Philip J. Ferrone, MD

Private Equity in Retina: Evaluating the PE Model
Philip J. Ferrone, MD

Has COVID-19 Changed the Practice of Retina (Forever)?
Darius M. Moshfeghi, MD

Retina Practice Implementation of E/M Changes and Guidelines
Mary Pat Johnson, COMT, CPC, COE, CPMA

Discussion/Q&A

CME Breakfast Seminar: Targeting Angiopoietin-2 in Retinal and Choroidal Vascular Diseases: A New Approach to Treatment

• Supported by an educational grant from Genentech, a member of the Roche Group
  Moderator: Rishi P. Singh, MD
  Faculty: David Eichenbaum, MD

Introduction and Pre-test
Rishi P. Singh, MD

The Role of Angiopoietins in Vascular Stability and Instability in Retinal and Choroidal Vascular Diseases
David Eichenbaum, MD

• Understanding how Ang 1 Tie2 promotes vascular stability and maintains homeostasis, while Ang 2 Tie2 drives vascular instability

Targeting Angiopoietin-2 in Retinal and Choroidal Vascular Diseases: Emerging Injectables
Rishi P. Singh, MD

• Review of clinical trials for razuprotafib, faricimab, and potential for AXT107

Posttest and Q&A
All Faculty

Pediatric Retina
Session Chairs: Cagri G. Besirli, MD, PhD; Vaidehi S. Dedania, MD; Eric D. Nudleman, MD, PhD

Announcements and Pretest

RD Repair in Self-inflicted Trauma
Vaidehi S. Dedania, MD

Anti-VEGF for ROP: Role of Adjunct Laser
Cagri G. Besirli, MD, PhD

Pediatric Retinal Conditions Seen in Adults
Eric D. Nudleman, MD, PhD

Cases in Pediatric Retina and Q&A

Exhibit Hall Break

Uveitis
Session Chairs: Yasha S. Modi, MD; Sunil K. Srivastava, MD

Vitreoretinal Lymphoma: When to Suspect This and How to Diagnose
Prithvi Mruthyunjaya, MD, MHS

How to NOT Miss Infectious Uveitis
Sunil K. Srivastava, MD

Preventing Endophthalmitis After Intravitreal Injection: What Do We Know
Vaidehi S. Dedania, MD

Uveitis for the Retina Surgeon: When to Intervene and When to Treat in the Clinic
Sunil K. Srivastava, MD

New Directions for Local Control of Intraocular Inflammation
Jorge A. Fortun, MD

Systemic Therapy for Uveitis: Considerations for use during COVID-19
Sunil K. Srivastava, MD

Discussion, Q&A and Posttest

CME Seminar: Targeting of the Complement System in Geography Atrophy: New Insights and Emerging Options for Treatment

• Supported by an educational grant from Apellis
  Moderator: Caroline Baumal, MD
  Faculty: Nathan C. Steinle, MD

Introduction and Pretest
Moderated by Caroline Baumal, MD

Assessing the Role of Complement in AMD
Caroline Baumal, MD

• Pathophysiology and the Role of Complement in AMD
  • Physiology of complement cascade activation - antibody-dependent, antibody-independent, and lectin pathways
  • Mechanism behind complement inhibition and effects on cell degeneration and death – C3, C5, MAC
• Discussion of previous agents for the treatment of GA: Eculizumab, LFG316, Lampalizumab, etc

Emerging Options that Target the Complement Cascade
Nathan C. Steinle, MD

• Emerging options that target the complement cascade in dry AMD and GA
• Review of clinical trial data on safety and efficacy for avacincaptad pegol, POT-4, APL-2 (pegcetacoplan), HMR59

Posttest and Q&A
All Faculty

Case Conference: Uveitis
Session Chair: Sunil K. Srivastava, MD
Session Panel: Yasha S. Modi, MD; David Sarraf, MD

Closing Remarks & Lunches to Go